TrialRadiation oncology (London, England)2026
Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.
Meng Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.